To present current information on the diagnosis, pathogenesis, natural history, and treatment of infantile hemangiomas.
Infantile hemangiomas are the most common vascular tumors of childhood. They are thought to be derived from embolized placental progenitor cells that lodge in privileged sites of the developing embryo. They exhibit a characteristic postnatal course with defined periods of growth and regression.
Multimodality intervention involving observation, medical therapy, laser photocoagulation, and surgery is the accepted modern approach. Timing of the intervention to obtain the best possible results in concert with developmental milestones is the goal. “Leave it alone—it will go away” is no longer universally acceptable advice for infantile hemangiomas.
. Examples of misdiagnosed and mistreated vascular anomalies. A, This patient was correctly diagnosed as having a hemangioma but was told, “Leave it alone—it will go away,” with an outcome unlikely to be acceptable. B, This patient's “hemangioma” was treated with vincristine chemotherapy, which had no effect on her venous malformation.
Histologic and clinical correlates of infantile hemangioma (IH) proliferation and involution. A, Histopathologic appearance of a proliferating IH showing a well-circumscribed, homogeneous lesion with plump endothelial cells and pericytes, mitotic figures, and a few small vessels. B, Clinical specimen of a proliferating IH showing the “solid” nature of the tumor. C and D, An IH during early and late involution showing flattening of endothelial cells, enlargement of lumina, and an increase in fibrofatty stroma. E, Clinical specimen in early involution showing a softer, less vascular tumor.
Clinical appearance of proliferating infantile hemangiomas (IHs). A, A superficial proliferating IH. B, A proliferating deep IH. C, A compound IH in early involution.
Glucose transporter protein 1 immunostaining of involuting infantile hemangioma endothelial cells. Glucose transporter protein 1 reactivity is pervasive throughout the proliferating and involutional stages.
Examples of acceptable and unacceptable involution of infantile hemangiomas. A, Acceptable result after involution of superficial infantile hemangiomas of the forehead and cheek by 2 years of age. B, Unacceptable result of full involution after 4 years, with expanded, telangiectatic skin.
Propranolol therapy (2 mg/kg/d divided into 3 doses) for a proliferating, compound hemangioma of the glabella. A, Pretreatment photograph. B, There is clear diminution in volume of the deep component and improvement of the superficial component. These changes occurred over a short period at an age (2-4 months) when most infantile hemangiomas are still proliferating. Whether the changes are coincidental or causal to the treatment is unclear, but they are the basis for the widespread interest in, and use of, this drug.
Compound involuting infantile hemangioma of the upper lip treated with surgery. A, An involuting compound infantile hemangioma of the upper lip that is not expected to involute to an acceptable result. The normal lip subunits are carefully marked, and measurements are transferred to the affected side. The tumor was resected in 1 stage, preserving normal skin and features. B, In 1 operation, more progress was made in alleviating this patient's facial difference than if years of continued involution were allowed to pass and a similar operation would likely have had to be performed.
Operative sequence of resection of compound infantile hemangioma in early involution. A-C, The superficial component was treated with the pulsed-dye laser while we were waiting for the child to achieve an adequate weight for elective anesthesia. Incisions are marked along the columellar edge, circumventing the soft-tissue triangles, and onto the alar grooves. D-G, A plane is developed between the deep component of the tumor and the skin, and the tumor is resected from the underlying lower lateral cartilages. An interdomal suture is used to approximate the cartilages without altering their shape. H-J, The expanded skin is redraped and, in this case, resected, while respecting the nasal subunits (ie, tip and ala). In some cases, the expanded soft-tissue envelope requires incisions that may involve crossing the subunits of the nose, a reality that is recognized by many articles in the literature (eg, references 31 and 32).
Thank you for submitting a comment on this article. It will be reviewed by JAMA Facial Plastic Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 12
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.